Dr. Bretschger received her B.S. in Physics and Astronomy at the University of Northern Arizona, and after a five-year career in aerospace and consulting, she completed a Ph.D. at the University of Southern California in Materials Science. Dr. Bretschger went on to lead the Electromicrobiology Group at the J. Craig Venter Institute from 2008-2017. Under her leadership, the group secured nearly $12M of external funding to better understand and develop bioelectrochemical technologies. Funding resulted from diverse resources including NASA, The State of California, The San Diego Foundation – Blasker Science and Technology Award, the National Science Foundation, the Office of Naval Research, SPAWAR, Synthetic Genomics Inc. and the Roddenberry Foundation. Dr. Bretschger’s 31 publications have drawn over 800 citations and her work has resulted in four patent filings, one awarded (internationally) and three pending.

Aquam Technologies LLC was founded by Dr. Bretschger in November 2016 with her partners Sofia Babanova, Rafael Calderon and Ryoji Naito. Aquam has secured qualified customer leads resulting in the potential for $500K of annual revenue in the coming year with a go-to market strategy focused in food and beverage. After successful demonstrations within the food and beverage vertical, Aquam will work to apply the technology toward other industrial, agricultural and military applications. Aquam’s goal is to be the leading provider of bioelectrochemical technologies for solving the world’s most challenging environmental problems.